Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2020

01-12-2020 | Breast Surgery | ASO Author Reflections

ASO Author Reflections: Improvement in Postoperative Pain, Nausea, and Vomiting After Implementation of an Enhanced Recovery Protocol for Breast Surgery

Authors: Kate H. Dinh, MD, MS, Emilia J. Diego, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

Enhanced recovery protocols (ERPs) use a multimodal, multidisciplinary approach to perioperative patient care. This approach enables clinical caregivers to design a coordinated protocol, with components working synergistically to optimize the shared goals of improved patient recovery. Multiple surgical subspecialties have developed ERPs with the aim of improving patient outcomes, specifically by decreasing postoperative pain via a multimodality approach to analgesia that also reduces perioperative opioid consumption, postoperative nausea and vomiting (PONV), and hospital length of stay. In addition, ERPs have been developed for mastectomy patients undergoing autologous reconstruction.1 However, ERPs have not been well studied among mastectomy patients not undergoing autologous reconstruction. …
Literature
1.
2.
3.
4.
5.
Metadata
Title
ASO Author Reflections: Improvement in Postoperative Pain, Nausea, and Vomiting After Implementation of an Enhanced Recovery Protocol for Breast Surgery
Authors
Kate H. Dinh, MD, MS
Emilia J. Diego, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09011-6

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue

Pancreatic Tumors

Comments on “Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma”

Breast Oncology

Letter to Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False-Negative Rate

ASO Author Reflections

ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?

ASO Author Reflections

ASO Author Reflections: Which Patients with Invasive Intraductal Papillary Mucinous Neoplasm Can Benefit from Adjuvant Therapy?

Correction

Correction to: Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin

ASO Author Reflections

ASO Author Reflections: The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-analysis